BFM
MDT icon

Boothbay Fund Management’s Medtronic MDT Stock Holding History

Boothbay Fund Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,700
Closed -$218K – 2262
2022
Q3 		$218K Buy
+2,700
New +$243K 0.01% 1770
2022
Q2 		– Sell
-6,000
Closed -$666K – 2499
2022
Q1 		$666K Buy
+6,000
New +$634K 0.02% 1147

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's MDT Position: Q1 2026 in Review

Boothbay Fund Management reduced its Medtronic (MDT) stake by 61% in Q1 2026, selling an estimated $549K and leaving 3,735 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Boothbay Fund Management first reported a position in MDT in Q1 2016 and has held it in 32 quarters since. The position peaked at $17.7M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Boothbay Fund Management held 3,735 shares of Medtronic worth $324K as of Q1 2026.
  • Boothbay Fund Management sold 5,735 Medtronic shares in Q1 2026, an estimated $549K.
  • Medtronic made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1576 holding.
  • Boothbay Fund Management first reported a position in Medtronic in Q1 2016 and has held it in 32 quarters since.
  • Boothbay Fund Management's Medtronic position peaked at $17.7M in Q1 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.